NCT04724603 Phage Safety Retrospective Cohort Study
| NCT ID | NCT04724603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Bone and Joint Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2021-02-01 |
| Primary Completion | 2022-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2021-02-01 with a primary completion date of 2022-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.
Eligibility Criteria
Inclusion Criteria: * patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event Exclusion Criteria: \-
Frequently Asked Questions
Who can join the NCT04724603 clinical trial?
This trial is open to participants of all sexes, studying Bone and Joint Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04724603 currently recruiting?
Yes, NCT04724603 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hospices Civils de Lyon to inquire about joining.
Where is the NCT04724603 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT04724603 clinical trial?
NCT04724603 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 25 participants.